Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in ...

Abbott's quarterly revenue fell short of analysts' expectations on Wednesday, as weakness in its diagnostics and nutritional businesses failed to offset strong demand for its medical devices.

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The healthcare landscape has changed dramatically since I first entered a surgical suite in ...

(Reuters) - Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter medical devices sales fell short of Wall Street ...

The development of new medical devices is accelerating rapidly due to many factors, including technological innovation, increased funding and a growing pool of talent. Bringing a medical device to ...

Medtronic recently won several medical device approvals from federal regulators for therapies where the company faces little or no competition. “It’s innovations in areas where there’s a big patient ...

Sales growth in the medical devices segment drove Abbott Laboratories’ expectations-beating revenue in the past financial quarter as the company faces lower demand for COVID-19 tests, it reported ...

Jan 25 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Wednesday reported lower-than-expected medical device sales for the fourth quarter as COVID-19 curbs in China and supply-chain issues ...